Z5A-28604-76245
3 vaccinations
1 coded response
14 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 027 / MA
- Registered
- 2022-01-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-05
Dose 1 — Moderna
-
2021-06-13
Dose 2 — Moderna
-
2022-01-15
Registered in v-safe
-
2022-01-15
Dose 3 — Moderna
- 2022-01-15
-
2022-01-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2022-01-17
- 2022-01-18
- 2022-01-21
- 2022-01-24
- 2022-01-29
- 2022-02-05
- 2022-02-14
- 2022-02-21
- 2022-02-28
- 2022-04-16
-
2022-07-18
Survey response — 6 months, dose 3MedDRA: Office visit, Thyroid cancer — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Thyroid cancer · Healthcare visit (other): SpecialistMedDRA releases: 2024-11 · check-in free text available
-
2022-07-18
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-07-19
- 2023-01-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-05 | Moderna | No |
| 2 | 2021-06-13 | Moderna | No |
| 3 | 2022-01-15 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-18 | Unsuccessful |
Free text
Release 12 — 6 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Thyroid cancer | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release